Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Aliivibrio salmonicida Shikimate dehydrogenase (aroE) CSB-YP469343AZM
CSB-EP469343AZM
CSB-BP469343AZM
CSB-MP469343AZM
CSB-EP469343AZM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aliivibrio salmonicida Diaminopimelate epimerase (dapF) CSB-YP469344AZM
CSB-EP469344AZM
CSB-BP469344AZM
CSB-MP469344AZM
CSB-EP469344AZM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aliivibrio salmonicida UPF0270 protein VSAL_I0295 (VSAL_I0295) CSB-YP469345AZM
CSB-EP469345AZM
CSB-BP469345AZM
CSB-MP469345AZM
CSB-EP469345AZM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aliivibrio salmonicida Pimelyl-[acyl-carrier protein] methyl ester esterase (bioH) CSB-YP469346AZM
CSB-EP469346AZM
CSB-BP469346AZM
CSB-MP469346AZM
CSB-EP469346AZM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aliivibrio salmonicida 50S ribosomal protein L23 (rplW) CSB-YP469347AZM
CSB-EP469347AZM
CSB-BP469347AZM
CSB-MP469347AZM
CSB-EP469347AZM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aliivibrio salmonicida 50S ribosomal protein L29 (rpmC) CSB-YP469348AZM
CSB-EP469348AZM
CSB-BP469348AZM
CSB-MP469348AZM
CSB-EP469348AZM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aliivibrio salmonicida 50S ribosomal protein L24 (rplX) CSB-YP469349AZM
CSB-EP469349AZM
CSB-BP469349AZM
CSB-MP469349AZM
CSB-EP469349AZM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aliivibrio salmonicida 50S ribosomal protein L17 (rplQ) CSB-YP469350AZM
CSB-EP469350AZM
CSB-BP469350AZM
CSB-MP469350AZM
CSB-EP469350AZM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aliivibrio salmonicida Purine nucleoside phosphorylase DeoD-type (deoD) CSB-YP469351AZM
CSB-EP469351AZM
CSB-BP469351AZM
CSB-MP469351AZM
CSB-EP469351AZM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aliivibrio salmonicida UPF0345 protein VSAL_II0656 (VSAL_II0656) CSB-YP469352AZM
CSB-EP469352AZM
CSB-BP469352AZM
CSB-MP469352AZM
CSB-EP469352AZM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aliivibrio salmonicida Tetraacyldisaccharide 4'-kinase (lpxK) CSB-YP469353AZM
CSB-EP469353AZM
CSB-BP469353AZM
CSB-MP469353AZM
CSB-EP469353AZM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aliivibrio salmonicida ATP-dependent dethiobiotin synthetase BioD (bioD) CSB-YP469354AZM
CSB-EP469354AZM
CSB-BP469354AZM
CSB-MP469354AZM
CSB-EP469354AZM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable exo-1,4-beta-xylosidase xlnD (xlnD), partial CSB-YP469355DOY
CSB-EP469355DOY
CSB-BP469355DOY
CSB-MP469355DOY
CSB-EP469355DOY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Penicillium chrysogenum Antifungal protein (afp) CSB-YP469356ETH
CSB-EP469356ETH
CSB-BP469356ETH
CSB-MP469356ETH
CSB-EP469356ETH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Penicillium chrysogenum Elongation factor G, mitochondrial (mef1), partial CSB-YP469357ETH
CSB-EP469357ETH
CSB-BP469357ETH
CSB-MP469357ETH
CSB-EP469357ETH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Penicillium chrysogenum Amino-acid acetyltransferase, mitochondrial (arg2), partial CSB-YP469358ETH
CSB-EP469358ETH
CSB-BP469358ETH
CSB-MP469358ETH
CSB-EP469358ETH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Penicillium chrysogenum Fe-S cluster assembly protein dre2 (dre2) CSB-YP469359ETH
CSB-EP469359ETH
CSB-BP469359ETH
CSB-MP469359ETH
CSB-EP469359ETH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Penicillium chrysogenum Required for respiratory growth protein 9, mitochondrial (rrg9) CSB-YP469360ETH
CSB-EP469360ETH
CSB-BP469360ETH
CSB-MP469360ETH
CSB-EP469360ETH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Penicillium chrysogenum Probable dipeptidyl-aminopeptidase B (dapB), partial CSB-YP469361ETH
CSB-EP469361ETH
CSB-BP469361ETH
CSB-MP469361ETH
CSB-EP469361ETH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Penicillium chrysogenum Nuclear distribution protein nudF 1 (nudF-1) CSB-YP469362ETH
CSB-EP469362ETH
CSB-BP469362ETH
CSB-MP469362ETH
CSB-EP469362ETH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>